The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer
NCT07590570 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 188
Last updated 2026-05-15
Summary
This is a multicentre study to investigate the association of fingernail lunula status with the efficacy and safety of neoadjuvant therapy in breast cancer patients.
Conditions
- Breast Cancer Invasive
Interventions
- DRUG
-
neoadjuvant therapy
patients receiving neoadjuvant therapy
Sponsors & Collaborators
-
Wenjin Yin
lead OTHER
Principal Investigators
-
Wenjin Yin · Renji Hospital, School of Medicine, Shanghai Jiaotong University
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2031-01-31
- Completion
- 2033-01-31
Countries
- China
Study Locations
More Related Trials
-
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.
NCT05263570 ·Status: RECRUITING
-
A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients
NCT06825975 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
NCT06591039 ·Status: RECRUITING
-
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
NCT06690645 ·Status: RECRUITING
-
The Association Between Blood Routine Parameters and Breast Cancer Prognosis
NCT07584213 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery
NCT04145973 ·Status: UNKNOWN
-
A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients
NCT06811870 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test
NCT04264468 ·Status: UNKNOWN
-
What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?
NCT03501394 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 ·Status: UNKNOWN
-
Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer
NCT02389673 ·Status: RECRUITING ·Phase: NA
-
Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer
NCT04509648 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis
NCT07283718 ·Status: ACTIVE_NOT_RECRUITING
-
Neoadjuvant Radiotherapy for Breast Cancer
NCT06313073 ·Status: RECRUITING ·Phase: NA
-
Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial
NCT06716073 ·Status: RECRUITING ·Phase: NA
-
Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients
NCT06795503 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy
NCT06161922 ·Status: RECRUITING
-
A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer
NCT06769919 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery
NCT06686459 ·Status: RECRUITING ·Phase: NA
-
Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Ductal Carcinoma in Situ
NCT02389699 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients
NCT04145947 ·Status: UNKNOWN
-
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
NCT05981014 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery
NCT02617043 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy
NCT06691594 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer
NCT03260192 ·Status: RECRUITING